Search research articles
Contact Us
Filters
Showing results (31-40 of 34) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 34 results.
Singapore Medical Journal
|
August 3, 2011
Effect of Ramadan fasting on serum heat shock protein 70 and serum lipid profile
A Zare, M Hajhashemi, Z M Hassan, et al.
Acta Virologica
|
June 16, 2010
HIV-1 Gag p24-Nef fusion peptide induces cellular and humoral immune response in a mouse model
M Mahdavi, M Ebtekar, K Azadmanesh, et al.
Journal of Neuroimmunology
|
September 2, 2014
Ginger extracts influence the expression of IL-27 and IL-33 in the central nervous system in experimental autoimmune encephalomyelitis and ameliorates the clinical symptoms of disease
A Jafarzadeh, M Mohammadi-Kordkhayli, R Ahangar-Parvin, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
December 31, 2011
The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cancer: study design
Andrew J Stewart Coats, Venkatesan Srinivasan, Jayaraman Surendran, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 34) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 34 results.
Singapore Medical Journal
|
August 3, 2011
Effect of Ramadan fasting on serum heat shock protein 70 and serum lipid profile
A Zare, M Hajhashemi, Z M Hassan, et al.
Acta Virologica
|
June 16, 2010
HIV-1 Gag p24-Nef fusion peptide induces cellular and humoral immune response in a mouse model
M Mahdavi, M Ebtekar, K Azadmanesh, et al.
Journal of Neuroimmunology
|
September 2, 2014
Ginger extracts influence the expression of IL-27 and IL-33 in the central nervous system in experimental autoimmune encephalomyelitis and ameliorates the clinical symptoms of disease
A Jafarzadeh, M Mohammadi-Kordkhayli, R Ahangar-Parvin, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
December 31, 2011
The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cancer: study design
Andrew J Stewart Coats, Venkatesan Srinivasan, Jayaraman Surendran, et al.
Page
of 4